Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 6
86
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Long non-coding RNA MEG3 and its genetic variant rs941576 are associated with rheumatoid arthritis pathogenesis in Egyptian patients

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 1571-1578 | Received 13 Jan 2020, Accepted 15 Jun 2020, Published online: 01 Jul 2020

References

  • Afuwape, A.O., Kiriakidis, S., and Paleolog, E.M., 2002. The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histology and histopathology, 17 (3), 961–972.
  • Alarcon, G.S., et al., 1982. Seronegative rheumatoid arthritis. A distinct immunogenetic disease? Arthritis and rheumatism, 25 (5), 502–507.
  • Aletaha, D., et al., 2010. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis and rheumatism, 62 (9), 2569–2581.
  • Al-Rugeebah, A., Alanazi, M., and Parine, N.R., 2019. MEG3: an oncogenic long non-coding RNA in different cancers. Pathology oncology research: pathology & oncology research, 25 (3), 859–874.
  • Arend, W.P., and Firestein, G.S., 2012. Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nature reviews. Rheumatology, 8 (10), 573–586.
  • Benetatos, L., Vartholomatos, G., and Hatzimichael, E., 2011. MEG3 imprinted gene contribution in tumorigenesis. International journal of cancer, 129 (4), 773–779.
  • Bottini, N., and Firestein, G.S., 2013. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nature reviews. rheumatology, 9 (1), 24–33.
  • Charan, J., and Biswas, T., 2013. How to calculate sample size for different study designs in medical research? Indian journal of psychological medicine, 35 (2), 121–126.
  • Chimenti, M., et al., 2015. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell death & disease, 6 (9), e1887
  • da Rocha, S.T., et al., 2008. Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends genet, 24 (6), 306–316.
  • Dechamethakun, S., and Muramatsu, M., 2017. Long noncoding RNA variations in cardiometabolic diseases. Journal of human genetics, 62 (1), 97–104.
  • Ghosh, S., and Castellanos-Rubio, A., 2019. Disease-associated SNPs in inflammation-related lncRNAs. Frontiers in immunology, 10, 420.
  • Guo, Q., et al., 2018. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone research, 6 (1), 15.
  • He, C., et al., 2017. Long Noncoding RNA MEG3 Negatively Regulates Proliferation and Angiogenesis in Vascular Endothelial Cells. DNA cell biol, 36 (6), 475–481.
  • Hu, F., et al., 2014. Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Annals of the rheumatic diseases, 73 (5), 928–936.
  • Hu, X.Q., et al., 2017. Chronic hypoxia upregulates DNA methyltransferase and represses large conductance Ca2+-activated K + channel function in ovine uterine arteries. Biology of reproduction, 96 (2), 424–434.
  • Ivan, M., et al., 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (New York, N.Y.), 292 (5516), 464–468.
  • Kiani, A.K., et al., 2015. Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients. Immunogenetics, 67 (5–6), 277–282.
  • Knijff-Dutmer, E., et al., 2002. Rheumatoid factor measured by fluoroimmunoassay: a responsive measure of rheumatoid arthritis disease activity that is associated with joint damage. Annals of the rheumatic diseases, 61 (7), 603–607.
  • Li, H., and Wan, A., 2013. Apoptosis of rheumatoid arthritis fibroblast-like synoviocytes: possible roles of nitric oxide and the thioredoxin 1. Mediators of inflammation, 2013, 953462.
  • Liang, J., Chen, W., and Lin, J., 2019. LncRNA: an all-rounder in rheumatoid arthritis. Journal of translational internal medicine, 7 (1), 3–9.
  • Liu, Y.R., et al., 2019. Long noncoding RNA MEG3 regulates rheumatoid arthritis by targeting NLRC5. Journal of cellular physiology, 234 (8), 14270–14284.
  • Lu, X., and Qian, J., 2019. Downregulated MEG3 participates in rheumatoid arthritis via promoting proliferation of fibroblast-like synoviocytes. Experimental and therapeutic medicine, 17 (3), 1637–1642.
  • Luo, G., et al., 2015. Long Non-Coding RNA MEG3 Inhibits Cell Proliferation and Induces Apoptosis in Prostate Cancer. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology, 37 (6), 2209–2220.
  • Mann, D.A., 2014. Epigenetics in liver disease. Hepatology (Baltimore, Md.), 60 (4), 1418–1425.
  • Motterle, A., Sanchez-Parra, C., and Regazzi, R., 2016. Role of long non-coding RNAs in the determination of beta-cell identity. Diabetes, obesity and metabolism, 18 (Suppl. 1), 41–50.
  • Nourshargh, S., and Alon, R., 2014. Leukocyte migration into inflamed tissues. Immunity, 41 (5), 694–707.
  • Peschansky, V.J., and Wahlestedt, C., 2014. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics, 9 (1), 3–12.
  • Qin, G., et al., 2006. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proceedings of the National Academy of Sciences of the United States of America, 103 (29), 11015–11020.
  • Quiñonez-Flores, C.M., González-Chávez, S.A., and Pacheco-Tena, C., 2016. Hypoxia and its implications in rheumatoid arthritis. Journal of biomedical science, 23 (1), 62.
  • Ruhrmann, S., et al., 2015. Genomic imprinting: a missing piece of the multiple sclerosis puzzle? The international journal of biochemistry & cell biology, 67, 49–57.
  • Rutenberg-Schoenberg, M., Sexton, A.N., and Simon, M.D., 2016. The properties of long noncoding RNAs that regulate chromatin. Annual review of genomics and human genetics, 17, 69–94.
  • Smolen, J.S., et al., 2018. Rheumatoid arthritis. Nature reviews. disease primers, 4, 18001.
  • Su, W., et al., 2015. The long noncoding RNA MEG3 is downregulated and inversely associated with VEGF levels in osteoarthritis. BioMed research international, 2015, 356893.
  • Sulaiman, F.N., et al., 2019. Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients. Medicine, 98 (12), e14945.
  • van der Heijde, D.M., et al., 1990. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Annals of the rheumatic diseases, 49 (11), 916–920.
  • Wallace, C., et al., 2010. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nature Genetics, 42 (1), 68–71.
  • Wang, G.L., et al., 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences of the United States of America, 92 (12), 5510–5514.
  • Weinmann, M., et al., 2004a. Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondrial apoptotic pathways. FASEB journal: official publication of the federation of American societies for experimental biology, 18 (15), 1906–1908.
  • Weinmann, M., et al., 2004b. Molecular ordering of hypoxia-induced apoptosis: critical involvement of the mitochondrial death pathway in a FADD/caspase-8 independent manner. Oncogene, 23 (21), 3757–3769.
  • Zhang, X., et al., 2019. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis. Journal of cellular and molecular medicine, 23 (10), 6708–6719.
  • Zhao, J., et al., 2005. Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. The journal of clinical endocrinology and metabolism, 90 (4), 2179–2186.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.